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ABSTRACT* 
Background: Over the course of recent years smartphone 
and tablet technology has evolved rapidly. Similarly, the 
sphere of healthcare is constantly developing and striving 
to embrace the newest forms of technology in order to 
optimise function. Many opportunities for mobile 
applications (i.e. ‘apps’) pertinent to the healthcare sector 
are now emerging.  
Objective: This study will consider whether registered 
pharmacists within the United Kingdom (UK) believe it 
appropriate to use mobile apps during the provision of 
healthcare within the community setting. 
Methods: Further to Liverpool John Moores University 
(LJMU) ethical approval, the 30 item questionnaire was 
distributed to UK registered pharmacists (n=600) 
practising within inner city Manchester, Liverpool and 
Newcastle. The questions were formatted as multiple 
choice, Likert scales or the open answer type. On 
questionnaire completion and return, data were analysed 
using simple frequencies, cross tabulations and non-
parametric techniques in the Statistical Package for the 
Social Sciences (SPSS) (v18). 
Results: The majority of respondents (78.4% of 211 
participants) confirmed that they were confident when 
using mobile apps on their technology platform. In general, 
mobile apps were perceived to be useful in facilitating 
patient consultations (55%) and supporting healthcare 
education (80%). The main barrier for mobile app use 
within the workplace was company policy, deemed 
significant in the case of regional / national chain 
pharmacies (p<0.001). Pharmacists alluded to the fact that 
whilst mobile apps demonstrate potential in modern day 
practise, they will have a greater impact in the future 
(p<0.001).  
Conclusion: The data indicate that although pharmacists 
are supportive of mobile apps in healthcare, a number of 
factors (i.e. risk, company policy and lack of regulation) 
may preclude their use in modern day pharmacy practise. 
Clearly, limitations of the technology must be addressed in 
order to maximise uptake within healthcare systems. 
Pharmacists suggest that as the younger generation ages, 
mobile apps will become a more accepted method by 
which to manage healthcare in the wider population. 
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INTRODUCTION 
Healthcare is constantly evolving. Modern 
technologies offer scope for more effective ways to 
manage disease. Over the course of the last two 
decades, the Internet has transformed the way in 
which information is accessed. Mobile devices (i.e. 
smartphone and tablet platforms) took this a step 
further by allowing users to have remote access to 
the World Wide Web at their fingertips. Such 
devices now outnumber personal computers and 
will soon become the most common way to access 
data.1 Interest generated in this technology may be 
ascribed to the availability of over one and a half 
million applications, or ‘apps’, available for 
download.2 Apps may be described as software 
packages that are used to enhance the efficiency of 
a device or to add functionality. Mobile apps can 
provide the healthcare professional with opportunity 
for a quick, user-friendly way of accessing important 
medical information to support patient care.3 
Mobile Applications for Community Pharmacy 
The introduction of the New Pharmacy Contract in 
2005 led to a dramatic change in the role of the 
community pharmacist.4 In brief, pharmacists must 
now execute a number of essential (i.e. prescription 
dispensing), advanced (i.e. ‘medicines use reviews’ 
(MURs) and ‘new medicines service’ (NMS)) and 
enhanced (i.e. smoking cessation) services that 
naturally place extra pressure on their daily routine. 
Clearly, finding the most efficient way of carrying out 
healthcare related tasks has never been so 
important.  
The availability of apps on portable devices may 
lead to a reduction in the time taken to carry out a 
particular service or task; this being a key benefit to 
the pharmacist. To be a useful healthcare tool, a 
mobile app should inform the decision making 
process, facilitate pharmacist / staff / patient 
education, act as a communication aid and provide 
support to the patient within the community setting.5  
With respect to the practice of pharmacy, mobile 
apps may be viewed as preferable to hard copy 
reference material due to their simplicity, user 
friendliness and regular updates. Here, it is 
illustrative to consider the fact that a number of 
pharmaceutically relevant organisations have 
produced mobile apps alongside traditional hard 
copy versions; for instance, The Royal 
Pharmaceutical Society British National Formulary 
(BNF) app allows healthcare professionals to 
access the BNF wherever they may be.6 Additional 
examples include ‘The Pharmacist Letter’ and 
‘Medscape’, which allow users to rapidly access 
relevant literature relating to a desired topic. 
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Furthermore, in 2011 DeArment investigated the 
suitability of pharmacy staff nominated as ‘Wellness 
Ambassadors’ who were equipped with tablet 
devices and asked to assist customers in the 
selection of over-the-counter medicines and 
vitamins, allowing them to make informed choices 
based on individual needs. The use of such 
technology was well received by both staff and 
customers, it was found to bridge a gap between 
front of store operations and the pharmacy, which 
was reported as being deficient.7  
Mobile platforms also lend themselves well to the 
management of chronic medical conditions such as 
diabetes (i.e. promoting safe insulin use and 
reducing the incidence of hypoglycaemia).8 A 
powerful feature common to all mobile devices is 
the capacity to connect to additional monitoring 
platforms via ‘sensing technology’. In this regard, 
Cai and coworkers considered the potential for 
Bluetooth technology to connect a smartphone to a 
glucose sensor in 2012.9 This strategy allowed the 
patient to store details of their blood glucose levels 
on a mobile device and then upload the data to the 
Internet for observation by a monitoring centre. If 
blood glucose levels were to reach pre-set 
thresholds an alarm would be triggered to send the 
patient a text with support information and if 
necessary details of nearest emergency contacts. 
This is an excellent example of “advanced 
healthcare-monitoring”.  
The technology may also serve to support 
healthcare education.10 Education within the 
healthcare setting is extremely important as there 
are frequent developments concerning new 
products and information. Naturally, this topic is 
extremely broad and a full / detailed explanation is 
beyond the remit of this document. However, 
aspects of relevance to mobile app use include 
pharmacist continuing education, staff training along 
with patient education. 
There is a fundamental expectation, from both 
regulatory bodies and the public, that all healthcare 
professionals hold an up-to-date knowledge-base in 
order to provide optimal healthcare.11 As part of 
current registration requirements, UK-based 
pharmacists are obliged to actively participate in 
continuing professional development (CPD).12 In 
brief, the strategy involves participation in learning 
activities and the collection of evidence with related 
reflection; the ultimate aim being to improve 
practice.13 Although the process is of educational 
value, studies suggest that the pharmacist often 
feels little need to complete CPD and they only 
undertake the exercise because it is a requirement 
stipulated by their profession.14 Here, mobile apps 
may be beneficial as they could offer both a rapid 
and convenient way in which to access medical 
information and facilitate the associated recording of 
learning activities.14  
Similarly, organisations providing pharmaceutical 
services are obliged to have training programmes in 
place and related assessment strategies to ensure 
healthcare staff provide safe and effective patient 
care.15 That is to say, there is an expectation that all 
employees hold a good working knowledge of the 
use and supply of medicines, including prescription 
and over the counter products.15 With respect to 
pharmacist prescribing, mobile apps may indeed be 
applied to aid the process within both the 
community and hospital sectors. For example, in 
2014 Haffey and co-workers considered the 
usefulness of mobile apps in assisting with the 
prescribing process in a hospital environment for 
inexperienced prescribers.16 Here, the group probed 
the practicality of 306 mobile apps for use both 
within and outside of the clinical setting. Overall a 
wide range of apps were noted to be available for 
use and a number of these were deemed 
appropriate to enhance prescribing performance. 
However, several limitations to the technology were 
outlined within the study (i.e. clinical reliability), 
which will be discussed in further detail within this 
article. Mobile apps may therefore hold potential to 
help pharmacists in gathering, contextualising and 
applying information to provide an effective clinical 
service.  
Moreover, in order to optimise treatment outcomes 
it is important that patients understand aspects 
relating to their medical condition(s) and associated 
management strategies (i.e. patients should be 
educated to a suitable level). Currently, several 
mobile apps are available for recommendation to 
educate the patient and include for example Cures 
A-Z, Wellnote and Diabetes UK Tracker.17 An 
interesting approach for patient education within the 
clinical setting is the use of digital video apps on 
mobile platforms. This particular route was 
investigated by Brock and Smith in 2007, where 51 
individuals in an outpatient infectious disease clinic 
at an academic medical centre were asked 
questions immediately before, immediately after and 
4-6 weeks after exposure to digital video on the 
assigned mobile platforms.18 Markers for 
investigation included patient understanding of their 
disease and treatment strategies along with 
adherence to medication. The group noted 
statistically significant improvements in patient 
understanding further to viewing the digital videos. 
Overall, it was concluded that the use of digital 
video on mobile platforms may be extremely useful 
to convey healthcare information and that the media 
was indeed patient friendly. 
Furthermore, scope exists for mobile apps to be 
utilised during patient consultations (i.e. MURs and 
NMS) with the pharmacist. Here, mobile apps such 
as Medscape may be applied to educate the 
patient, enhance compliance and adherence.17 With 
respect to the latter point, Dayer and colleagues 
considered the possibility of using mobile apps to 
improve medication adherence.19 At the time, the 
group suggested that mobile apps offer a fresh 
route for patients to derive the maximum benefit 
from treatment regimens (i.e. by reminding the 
patient to follow the treatment plan). The principal 
finding from this particular research study was the 
fact that mobile apps do indeed hold great potential 
to support non-adherent patients. 
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Barriers to Mobile App Use in Community 
Pharmacy 
Although mobile apps appear to demonstrate 
promise in the field of healthcare, a number of 
issues surrounding the use of such technology 
exist. For instance, patient age may significantly 
hinder uptake. Should the patient belong to the 
‘older generation’ it is unlikely, but not impossible, 
they would utilise the technology platforms due to 
lack of familiarity. Organisations may have in place 
company policies that preclude the widespread use 
of mobile devices in the working environment.20 
Additionally, poor store network coverage can 
interfere with those apps that require an internet 
connection.  
A further prohibitive point associated with such 
technology involves the aspects of reliability and 
accuracy of the software platforms.21 Healthcare 
professionals may indeed be disinclined to use 
mobile apps should they hold concerns regarding 
suitability of use, a fact that may be attributed to our 
increasingly litigious societies. Naturally, these are 
all valid concerns relating to the use of mobile apps 
in the modern day healthcare setting and are 
investigated in greater detail within this piece.  
Lead In 
Mobile technology is becoming ever more 
prominent within society and is now unavoidably 
filtering into the healthcare arena. To date, limited 
research has been conducted to establish opinions 
held by pharmacists towards the use of mobile apps 
in healthcare.22 As a consequence, we believe it to 
be both timely and appropriate to consider the views 
held by pharmacists towards the use of mobile apps 
within the community setting. 
 
METHODS  
Questionnaire Preparation and Ethical Approval 
Prior to study execution, a thorough literature review 
was conducted in order to identify current opinion 
regarding the use of mobile apps within the 
community pharmacy setting. Upon inspection of 
the published material, it was evident that important 
themes included the level of confidence a 
pharmacist has when using a mobile app, whether 
mobile apps have a role in modern day community 
pharmacy, the suitability of using a mobile app 
when compared to a hard reference source, the 
appropriateness of using a mobile app during 
patient consultations and barriers that may prevent 
the use of mobile apps. To this end, typical 
questions for the participants included:  
1. How confident do you feel in using mobile apps? 
2. To what extent do you believe healthcare apps 
have a place in modern day community 
pharmacy? 
3. How comfortable would you be in using a mobile 
app over a hard copy reference source? 
4. Mobile apps offer scope to aid the pharmacist 
during patient consultations (i.e. MURs and 
NMS). 
5. Which of the following, if any, would present as a 
barrier to using mobile apps in your pharmacy? 
The questionnaire was prepared using a range of 
Likert statements based upon the recurrent themes. 
For instance, the Likert scales involved: ‘To a great 
extent’, ‘To a moderate extent’, ‘To some extent’, 
‘To a small extent’ and ‘To no extent’. In addition, 
opportunity was given for respondents to offer their 
views in ‘free-text’ boxes to enable the reasoning of 
key trends noted within the data. Further to 
completion of the questionnaire and support 
materials (i.e. cover letter and participant 
information sheet) ethical approval was sought and 
obtained by the Liverpool John Moores University 
(LJMU) ethics committee.  
Questionnaire Distribution  
During January 2013, a questionnaire pack was 
distributed to 600 community pharmacies located 
within inner city Liverpool, Manchester and 
Newcastle. The pack consisted of a 30 item 
questionnaire, a covering letter, a participant 
information leaflet along with an A5 freepost 
response envelope for document return and 
confirmation of consent. At all times the information 
remained confidential. The questionnaires were 
coded for tracking purposes. In an attempt to 
improve the response rate, follow up calls were 
made to those pharmacies who did not respond 
after two weeks of receiving the questionnaire; if 
necessary, the questionnaire completed over the 
telephone or another questionnaire pack dispatched 
if requested.  
Statistical Analysis 
The data were collated and entered into the SPSS 
v18 platform to allow appropriate analysis; all 
entries were validated via triple inspection. Initially, 
descriptive tools were employed to obtain simple 
frequencies and cross-tabulations for the more 
basic type of question (i.e. How confident do you 
feel in using mobile apps?). Non-parametric 
techniques were utilised in the data analysis as 
these do not require a normal distribution in the 
identification of underlying trends. Here, cross 
referencing between demographic questions and 
opinions (i.e. those enquiries containing Likert 
scales) included the Mann-Whitney test along with 
the Kruskal-Wallis test and the p values were then 
recorded; where a p-value of less than or equal to 




A total of 211 completed questionnaires were 
received from UK registered pharmacists; thus 
providing a response rate of 35.1% for this study. 
The participants included 102 females (48.3%) and 
103 males (48.8%). With respect to age, the cohort 
were assigned to two brackets; namely between 21-
35 years old (60.7%) and over 35 years old 
(36.5%). Respondents were grouped as either 
‘pharmacy managers / owners’ (61.1%) or 
‘employee / locum / relief pharmacists’ (36%). In the 
main, pharmacy premises were linked to a regional 
or national chain (60.2%) with others being 
members of local group or single independents 
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(37%). Participants possessed a wide ranging level 
of experience, with 119 people having practised for 
10 years or less (56.4%) and 86 participants 
working for 10 years or more (40.8%). Within the 
study group 6 individuals failed to provide 
demographic information. 
Study Data 
PHARMACISTS LEVEL OF CONFIDENCE AND 
COMFORT IN MOBILE APP USE 
The data suggest that those pharmacists surveyed 
were confident when using mobile apps on portable 
devices. The majority of respondents (78.4%) 
agreed that they held a degree of confidence when 
using mobile apps, with only a small minority (2.5%) 
of individuals stating that they were not at all 
confident. The trend in the data is to be expected as 
smartphone and tablet devices are now becoming 
engrained within society and it is expected that 
pharmacists would be use the technology on a daily 
basis. 
Participants were subsequently invited to consider 
whether they would be comfortable in using a 
mobile app over a hard copy reference source, the 
results are presented in Figure 1.  
In the main, respondents were comfortable in using 
mobile apps to acquire information located within 
traditional reference sources (i.e. BNF / Martindale). 
However, it was apparent that pharmacists 
demonstrated a degree of caution in this regard as 
illustrated by: 
“It depends on the app; I would only use a 
referencing app if it were from an official 
source such as the BNF app.” Pharmacist 
A. 
“I’d only be happy to use and buy an 
application which was from an official body 
or organisation such as the BNF or NHS” 
Pharmacist B. 
Furthermore with respect to daily practise, 
participants were asked to consider to what extent 
they agreed mobile apps have a role to play in 
providing advanced services to patients, the data 
are illustrated in Figure 2. 
Upon inspection, it is evident that just over half of 
the respondents (55%) agreed that mobile apps 
may offer potential to facilitate effective advanced 
service provision. However, a number of 
respondents suggested that the use of mobile apps 
may not be appropriate during patient consultations: 
“If I have my phone out when talking to a 
patient, they often find it unprofessional” 
Pharmacist C. 
“Older patients may find it rude if I use my 
phone during a consultation, I’ve had odd 
reactions before when simply using the 
calendar.” Pharmacist D. 
Overall, the data suggest that whilst the majority of 
pharmacists surveyed believe mobile apps may 
offer potential to aid patient consultations, care must 
be taken to ensure individuals are not offended 
when mobile technology is used during clinically 
important discussions. 
THE SUITABILITY OF MOBILE APPS IN 
HEALTHCARE EDUCATION 
Mobile apps may be employed within the healthcare 
setting to facilitate pharmacist, staff and patient 
education. Consideration was initially given to the 
suitability of mobile apps in pharmacist continuing 
education, the results are displayed in Figure 3. 
Upon inspection, the majority of pharmacists 
(80.5%) suggested that they would likely engage 
(i.e. very, quite or somewhat likely) with mobile apps 
to support their continuing education. Only a small 
minority of the sample (19.4%) did not perceive 
mobile apps as useful tools to aid in the continuing 
education process. A number of supportive 
Figure 1. Pharmacist Level of Comfort with using a Mobile App over a Hard Copy Reference Source 
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comments obtained from the pharmacists involved 
with the study included:  
“I am seeing trends developing in the 
direction of apps for pharmacist’s continuing 
education” Pharmacist E. 
“Recording CPD on my phone would be 
very handy” Pharmacist F. 
“I already use the CPPE monthly quiz app 
so I would be happy to use others.” 
Pharmacist G. 
With the use of mobile apps for staff training in 
mind, the respondents did in fact demonstrate a 
degree of comfort. Here, a total of 78.2% of those 
surveyed suggested that they were comfortable (i.e. 
very, quite or somewhat) in using mobile apps to 
facilitate staff training within the pharmacy. In a 
similar manner to the data presented above, a 
minority (21.8%) were not fully comfortable in using 
the technology to assist with staff training.  
In relation to these points, the respondents 
appeared to be relatively content in using mobile 
apps for patient education purposes. The majority of 
individuals (80.1%) were generally (i.e. very, quite 
or somewhat) content with utilising mobile apps 
during periods of patient education; it was evident 
that 14.7% of individuals questioned were ‘very 
content’ to use mobile apps for this reason.  
It is interesting to note the parallel within the data 
sets relating to pharmacist education, staff training 
and patient education. In all cases, the participants 
demonstrated a general agreement that mobile 
apps may indeed hold a role in the education of 
individuals within the modern day healthcare 
setting. 
All participants were asked to consider whether they 
would or would not recommend a mobile app for a 
Figure 2. Mobile Apps Offer Scope to Aid the Pharmacist during Patient Consultations (i.e. MURs and NMS)
Figure 3. The Likelihood of Pharmacists using Mobile Apps for Continuing Education Purposes 
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range of medical conditions that may present on a 
daily basis within the pharmacy; namely weight loss 
and exercise, general health issues, sleep and 
meditation, pregnancy, disease management and 
smoking cessation. The data acquired for this 
element of the study is presented within Figure 4.  
The results indicate that the respondents would be 
more likely to recommend mobile apps to support 
weight loss (73.5%), general health issues (65.4%) 
and smoking cessation (56.4%) within the 
community pharmacy setting. The participants 
appeared less willing to recommend mobile apps for 
sleep and meditation (70.6%), pregnancy (67.8%) 
and disease management (65.9%). On reflection, a 
clear mismatch presents within the data set, which 
may be attributed to the level of risk perceived to 
both the pharmacist and the patient. 
BARRIERS TO MOBILE APP USE IN THE 
WORKPLACE 
Participants were invited to consider practical 
limitations to mobile app use within the community 
pharmacy setting; aspects for reflection included 
company policy, network coverage, battery life, time 
available for use and the cost of the mobile app. 
Here, the type of pharmacy was specifically 
considered. The data obtained from this arm of the 
study are presented in Table 1. 
Upon inspection of the data, it is evident that all 
highlighted parameters impose some form of 
limitation on the use of mobile apps within the 
workplace. However, statistical significance was 
only apparent in the case of company policy 
(p=0.000). It is apparent that pharmacists working 
within a regional or national chain were more likely 
to suggest that company policy would limit mobile 
app use when compared to counterparts employed 
within independent / local pharmacy outlets.  
THE ROLE OF MOBILE APPS IN MODERN DAY 
AND FUTURE PHARMACY PRACTISE 
The participants were finally asked to consider the 
role of mobile apps in both modern day pharmacy 
practise and the future of pharmacy practice. The 
data acquired from the element are illustrated in 
Figure 5. 
Upon inspection of the data, it is evident that the 
bulk of pharmacists questioned (75.9%) believed 
that mobile apps hold a role in modern day 
pharmacy practise (i.e. to a great, moderate or 
some extent). However, it is clear that most 
pharmacists (89.6%) believed that mobile apps will 
be of great importance in the future (i.e. to a great, 
moderate or some extent). Overall, the views held 
by pharmacists regarding modern day use of mobile 
apps compared to future use of mobile apps were 




Further to the implementation of the UK New 
Pharmacy Contract in 2005, community pharmacy 
Table 1.  Barriers to the use of Mobile Apps within the Community Pharmacy Setting 
Barrier 
Type of Pharmacy 
Significance Level Independent / Local Pharmacy Regional / National Chain 
Yes No Yes No 
Company Policy 33 45 94 33 0.000 
Network Coverage 31 47 62 65 0.206 
Battery Life 15 63 30 97 0.462 
Time 22 56 26 101 0.205 
Cost of App 14 64 46 81 0.005 
Figure 4. Pharmacist willingness to recommend a mobile app for a range of commonly presenting conditions 
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service models have changed significantly. 
Pharmacists practising within more developed 
countries (i.e. the UK and USA) now participate 
much more actively in delivering healthcare to the 
public. In a seemingly unrelated dimension, notable 
advances have been made within the field of mobile 
technology. The popularity of both smartphone and 
tablet devices has soared and as such this 
technology now appears to be feeding into modern 
day healthcare frameworks.  
This preliminary study has considered the potential 
in combining these largely independent aspects in 
order to enhance the patient experience and health 
related outcomes within the community pharmacy 
setting. To date, limited research has been 
conducted to ascertain community pharmacist’s 
perceptions relating to the use of mobile technology 
during service provision. With this technology 
market becoming an emerging force, exploration 
into the use of mobile apps in the field of pharmacy 
has never been more pertinent. 
Pharmacist Confidence with Mobile App Use 
In general, respondents indicated that they felt 
confident when using mobile apps. This finding may 
be ascribed to the way in which mobile devices 
have now become entrenched within society and 
the fact that it is highly likely that pharmacists would 
be proficient in using such platforms. Clearly, the 
level of confidence noted would enable the 
individual to derive maximum benefit from using a 
mobile app without it hindering daily workflow 
patterns. Here, the efficiency of use could facilitate 
decision making, aid in education and also expedite 
inter-individual communication, for example. With 
respect to those who did not express confidence 
when using mobile apps, opportunity exists to 
provide training (i.e. via workshops or tutorials) to 
improve understanding and competence, hence 
allowing for effective mobile app use in the 
workplace. 
Mobile Apps as Pharmacy Reference Sources 
The majority of participants were in favour of using 
mobile apps as reference sources. A number of 
reasons exist to explain this finding including for 
instance ready access to sources of information at 
the touch of a fingertip. A benefit such as this may 
lead to reduced waiting times and improvements in 
the patient counselling process. Arguably, one of 
the key advantages of using mobile apps in the 
healthcare setting is the capacity to rapidly access 
the most up-to-date medical information to assist in 
patient care. For instance, clinical guidelines (i.e. 
NICE guidance23) may be updated regularly but a 
pharmacist may not be able to directly access to the 
most up-to-date information due to the static nature 
of a hard copy source.  
With the majority of approved healthcare 
organisations within the UK now offering access to 
mobile apps NHS staff / private contractors may 
have access to relevant, up-to-date information at 
the point of care.24 This arrangement may offer the 
potential for staff to roam freely within the workplace 
without the hindrance of having to carry a hard copy 
reference source(s). 
Although the availability of clinical guidelines and 
medical information does appear favourable, 
understandably a number of respondents revealed 
concerns regarding the use of unregulated mobile 
apps during service provision. In this regard, it is a 
reasonable expectation that healthcare staff require 
such software platforms to be robust, reliable and 
safe; given the litigious nature of society. To ensure 
effective uptake and use of mobile apps in 
community pharmacy, certified apps from either 
accredited external organisations or indeed the 
employer should be devised and established.  
Mobile Apps and Patient Consultations 
Overall, respondents were not overwhelmingly in 
favour of using mobile apps during patient 
consultations, a result that may be attributed to the 
Figure 5. Pharmacist Opinion Regarding the Use of Mobile Apps in Modern Day and Future Practise 
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pharmacist perception of how the patient identifies 
with the consultation process as a whole. During a 
typical consultation, a pharmacist would engage 
with the patient and discuss medical information 
tailored specifically to that patient. Should a mobile 
app supported on a personal smartphone be used 
at this juncture, the patient may hold a negative 
view and perceive the technology platform as an 
obstacle to communication.  
We therefore suggest that the type of mobile 
platform (i.e. smartphone or tablet device) used 
during patient consultations is pivotal for 
acceptance. Clearly, a company owned tablet 
device would enable the pharmacist to project a 
professional appearance whilst minimising any 
obstacles during the consultation process. This 
device type would be suitable because it would offer 
an interactive route by which to learn about disease 
and related management, it could allow ready 
visualisation of medicines use (i.e. correct inhaler 
technique) and could allow the pharmacist to update 
medical records at the touch of a button.  
An excellent example of a recently released mobile 
app for use during patient consultations is the 
Boehringer Ingelheim software package called 
‘COPD Exchange’, which may aid the community 
pharmacist during chronic obstructive pulmonary 
disease (COPD) consultations.25 It is approaches 
such as this that will enhance the patient experience 
within community pharmacy. 
Mobile Apps in Healthcare Education 
PHARMACIST CONTINUING EDUCATION (CE) 
AND STAFF TRAINING 
Respondents suggested that they would engage 
with mobile apps to support their continuing 
education (CE) and staff training. Undoubtedly, 
mobile apps offer the pharmacist potential to 
conveniently engage with healthcare education and 
allow for ease of recording entries; points never 
more important with current workloads in mind.4 
Overall, the use of such technology for CE purposes 
is fitting at this point in time as there is now 
increased emphasis placed on pharmacists to 
engage with lifelong learning and log the events on 
the General Pharmaceutical Council (GPhC) 
website, thus the easy access to such platforms 
would satisfy mandatory professional 
requirements.12 
However, perhaps one reason for the apparent 
reservation is the fact that pharmacists believe that 
CE would be best delivered by recognised or 
accredited training sessions and direct reference to 
the literature (i.e. journal articles). In this case, 
pharmacists may not consider mobile apps to be 
suitable for the sole purpose of CE and staff 
training. Indeed, we would fully support this view. 
Consequently, we suggest a balance be struck to 
enable effective use of mobile apps in lifelong 
learning or staff training. In this case, the 
pharmacist may attend training events and actively 
engage with training material, once complete mobile 
apps can be used consolidate taught material and 
record learning events. In the future we envisage 
mobile apps being routinely used to enhance 
pharmacists / staff learning experiences, and 
deepen levels of learners' engagement and 
collaboration within a digital learning environment.26 
PATIENT EDUCATION / SUPPORT 
Those pharmacists surveyed indicated that they 
would promote mobile apps for weight loss and 
exercise, general health issues along with smoking 
cessation. However, the categories of sleep and 
meditation, pregnancy and disease management 
garnered limited support. The trend in the data may 
be linked directly to the level of risk perceived by the 
pharmacist. Risk can be defined as exposing 
someone to possible harm.27 Arguably, the most 
important role of a pharmacist is to safeguard 
patients and hence minimise risk associated with 
treatment regimens (i.e. adverse drug reactions / 
interactions).28  
The data suggest that pharmacists are more likely 
to recommend apps for ‘low risk’ conditions (i.e. 
smoking cessation) when compared to the more 
‘high risk’ conditions (i.e. pregnancy). The results 
may be explained by the fact that mobile apps or 
alert mechanisms (i.e. SMS) for the more ‘high risk’ 
conditions hold potential to cause long term damage 
should they be incorrectly used or originate from an 
untrustworthy source.29 Pharmacists appear to be 
comfortable in recommending mobile apps for 
patients with conditions that do not have the 
potential of a sudden health decline. The finding 
aligns well with the work of Phipps and co-workers 
who consider the practice of pharmacy as ‘socio-
technical’ in nature, meaning that there are two 
sides to consider when considering risk in 
pharmacies (i.e. patient risk and the risk when 
providing pharmaceutical support).30 The group 
clarifies that incorporating risk assessment into 
pharmacy practice is vital and pharmacists must be 
fully aware of the repercussions of their actions (i.e. 
those actions associated with mobile app use). We 
would argue that regulation is central to mobile app 
uptake. Should a mobile app receive accreditation 
then the pharmacist will be safe in the knowledge 
that it is fit for purpose and would then be more 
likely to recommend it to manage a range of 
commonly occurring medical conditions, due to the 
reduction in risk.  
In terms of patient support, mobile apps may 
enhance the provision of more advanced services 
such as MURs and also guide the patient with 
complex medication regimens. During patient 
consultations tablet devices, for example, could 
enable access to up-to-date medical records at the 
touch of a button and also present educational 
material (i.e. videos) relating to medicine use (i.e. 
correct inhaler technique) or the medical condition 
they have in an interactive manner. Indeed, a study 
conducted by Strayer and co-workers in 2010 
demonstrated that patients were mainly in favour of 
the use of tablet devices and related content during 
consultations with prescribers.31  
In addition, apps may hold value in reminding the 
patient when to take their medication. In the UK 
hundreds of millions of pounds are lost each year as 
a result of medication wastage; a large proportion of 
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this loss may be linked to patient non-compliance.32 
Furthermore, it is estimated that a total of 7 million 
people missed scheduled hospital appointments, 
causing delayed treatment time to other patients 
and costing the National Health Service (NHS) 
millions of pounds. Clearly patient reminders sent 
via mobile apps present as an ideal route to 
minimise issues such as these.33 Indeed, 
programmes such as the Managed Appointment 
Reminder Service (MARS) aim to reduce the 
financial loss reported by the NHS. This particular 
service has successfully been piloted in The Hull 
and East Yorkshire Hospital.34  
Barriers to Mobile Apps in the Workplace 
Respondents suggested that a number of issues 
(i.e. network coverage and battery life) restricted the 
use of mobile apps within the workplace. The data 
clearly indicate that company policy was the major 
limitation to mobile app use, which may be linked 
directly to the employer viewing mobile devices as 
distracting for the pharmacist.35,36 Also, it is evident 
that the type of pharmacy in which a pharmacist 
practises holds a large impact on this element. For 
instance those individuals who work within 
independent / small local group pharmacy perceive 
the issue to be a minor problem, with the opposite 
true for counterparts employed in regional / national 
chains. Consequently, it is feasible to propose that if 
such policies remain mobile apps will have a limited 
role in the provision of healthcare to the public in the 
future.20 In order to circumvent this issue, we 
propose mobile device management strategies 
should be implemented.37 Irrespective of the format 
of the pharmacy, all premises must be viewed as 
retail businesses that provide a clinically relevant, 
professional service.4 To this end, the uptake of 
mobile apps within the community pharmacy setting 
would require thorough planning and evaluation. 
Here, we envisage the tailoring of mobile apps to 
the specific organisation(s) being the way forward to 
improving general acceptance.7,38  
The Suitability of Mobile App use in Modern and 
Future Practise 
Those pharmacists surveyed hold value in the use 
of mobile apps for both modern day practice and 
particularly future practice. It is interesting to 
consider, at this juncture, the UK population 
demographic and how may influence mobile app 
use within the community setting. The UK currently 
has an ageing population, with the number of 
elderly people set to double from 10 to 20 million by 
2050.39 At this point in time, the relatively large 
number of individuals described as the ‘older 
generation’ would be either unable or unwilling to 
use mobile apps to support their health needs.20 
However, the current ‘younger generation’ is much 
more likely to embrace the use of mobile apps in 
healthcare plans because they are accustomed to 
such technology. Over the course of time as the 
younger generation ages and naturally ‘replaces’ 
the current older generation, the use of apps as part 
of a treatment plan is much more likely to become 
prevalent. It is conceivable, therefore, that mobile 
apps may hold a central position in the future 
delivery of healthcare.
CONCLUSIONS 
In general, those pharmacists surveyed were in 
favour of mobile app use within the community 
setting. Although the participants expressed comfort 
in using mobile apps, several concerns were 
declared. Pharmacists alluded to the fact that 
mobile apps must be accredited to ensure the 
information provided is accurate and trustworthy. 
Concern was aired regarding the suitability of use of 
a mobile device during patient consultations. 
Company policy, as it stands at the moment, may 
indeed be a major stumbling block for the use of this 
technology. Undoubtedly, drawbacks such as these 
must be addressed to ensure effective uptake of 
mobile apps in supporting patient care.  
We recommend further work be performed to better 
understand this field. To this end, it would be 
beneficial to probe the opinions held by both the 
public and service providers. To enable effective roll 
out, it is important to ensure that all parties involved 
with such technology are content. If a deeper 
understanding of current opinion surrounding the 
use of mobile apps in the community pharmacy is 
gained, scope exists to develop the technology 
accordingly and thus provide a promising new route 
by which to provide pharmaceutical care within the 
community setting. 
   
ACKNOWLEDGEMENTS 
The authors would like to express their gratitude to 
all participants who took part in this study. Our 
special thanks go to Dr Phil Rowe for support during 
statistical analysis and LJMU for funding this 
research effort. 
 
CONFLICT OF INTEREST 
None declared. 
 
APPS DE FARMACIA: UNA NUEVA FRONTERA 
EN EL PAISAJE DIGITAL? 
 
RESUMEN 
Antecedentes: La tecnología de smatphones y tablets ha 
evolucionado rápidamente en el transcurso de los últimos 
años. Igualmente, la esfera de la sanidad está 
constantemente en desarrollo y esforzándose para incluir 
las nuevas formas de la tecnología para optimizar su 
funcionamiento. Están apareciendo muchas 
oportunidades para las aplicaciones de móviles (i.e., 
‘apps’) en el sector de la salud.  
Objetivo: este estudio considera si los farmacéuticos 
registrados en el Reino Unido (UK) creen apropiado el 
uso de apps de móviles durante la atención a la salud en 
el entorno comunitario. 
Métodos: Después de la aprobación de ética de la 
Liverpool John Moores University (LJMU), el 
cuestionario de 30 ítems fue distribuido a los 
farmacéuticos registrados en UK que trabajaban en la 
ciudad de Manchester, Liverpool and Newcastle (n=600). 
Se formatearon las preguntas como escalas de Likert de 
selección múltiple o de tipo abierto. Cuando completaron 
y devolvieron los cuestionarios, se analizaron los datos 
usando frecuencias simples, tablas de contingencia y 
métodos no paramétricos en el SPSS (v18). 
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Resultados: La mayoría de los respondentes (78,4% de 
211 participantes) confirmaron que sentían confianza 
cuando usaban apps de móviles en sus plataformas 
tecnológicas. En general, las apps de móviles eran 
percibidas como útiles para facilitar la consulta con el 
paciente (55%) y apoyar la educación sanitaria (80%). La 
principal barrera para el uso de apps de móviles en el 
lugar de trabajo era la política de la compañía, lo que 
resultó significativo en el caso de cadenas de farmacias 
regionales / nacionales (p<0,001). Los farmacéutico 
aludieron al hecho de aunque las apps de móviles 
demuestran un potencial en la práctica diaria moderna, 
tendrán mayor impacto en el futuro (p<0,001). 
Conclusión: Los datos indican que aunque los 
farmacéuticos son favorables a las apps de móviles en la 
atención sanitaria, determinados factores (i.e., riesgo, 
política de compañía y falta de reglamentación) pueden 
impedir su uso en la práctica diaria moderna. Claramente, 
deben afrontarse las limitaciones de la tecnología para 
maximizar su beneficio en los sistemas sanitarios. Los 
farmacéuticos sugieren que, a medida que las 
generaciones más jóvenes crezcan, las aplicaciones de 
móviles serán un método más aceptado para la atención 
sanitaria en mayores poblaciones. 
 
Palabras clave: Teléfono Móvil; Ordenadores de 
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